Kindred Biosciences Inc (NYSE:KIN) released its quarterly earnings data on Thursday. The biopharmaceutical company reported ($0.27) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.32) by $0.05, MarketBeat reports. In other Kindred Biosciences news, Director Ernest Mario bought 30,000 shares of the company’s stock in a transaction on Tuesday, March 15th. The […]
